Kevin Charles Gorman, Chief Executive Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 6,780 shares at $118.91 ($806K) on 2020-08-05, disclosed to the SEC on 2020-08-07.
Open-market sale of $806k NBIX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.91 | 3,390 | $403K | 50.0% |
| 2 | $118.91 | 3,390 | $403K | 50.0% |
| Total | $118.91 avg | 6,780 | $806K | 100% |
| Filing → |
| NBIX | SELL | 2025-08-11 | $26.9M | — | Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |